BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30888206)

  • 1. Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese Population.
    Liu J; Tang W; Lin W; Wang Y; Chen Y; Wang J; Liu M; Xu W; Lin J; Zhang L
    DNA Cell Biol; 2019 May; 38(5):443-448. PubMed ID: 30888206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of CTLA-4 polymorphism and the risk of gastric cancer in a Chinese Bai population.
    Yan P; Kong S; Zheng Y; Cheng M; Zhao W
    Int J Immunogenet; 2023 Oct; 50(5):256-263. PubMed ID: 37495903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cytotoxic T-lymphocyte antigen 4 gene polymorphisms and primary biliary cirrhosis in Chinese population: data from a multicenter study.
    Li Q; Wang B; Pan F; Zhang R; Xiao L; Guo H; Ma S; Zhou C
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1397-402. PubMed ID: 23432218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
    Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
    Front Immunol; 2021; 12():607966. PubMed ID: 33717091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort.
    Cai GM; Gao Z; Yue YX; Xie YC; Gao X; Hao HJ; Zhang XJ; Wang Q; Liang B; Li HF
    J Clin Neurosci; 2019 Nov; 69():31-37. PubMed ID: 31473094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma.
    Tang W; Wang Y; Chen S; Lin J; Chen B; Yu S; Chen Y; Gu H; Kang M
    Scand J Immunol; 2016 Mar; 83(3):212-8. PubMed ID: 26709093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.
    Guo Y; Gao J; Gao S; Shang M; Guo F
    Oncotarget; 2016 Apr; 7(17):23088-95. PubMed ID: 27081086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.
    Chen X; Hu Z; Liu M; Li H; Liang C; Li W; Bao L; Chen M; Wu G
    BMC Med Genet; 2018 Sep; 19(1):171. PubMed ID: 30223781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers.
    Hadinia A; Hossieni SV; Erfani N; Saberi-Firozi M; Fattahi MJ; Ghaderi A
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2283-7. PubMed ID: 18031393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two genetic variants in prostate stem cell antigen and gastric cancer susceptibility in a Chinese population.
    Wu C; Wang G; Yang M; Huang L; Yu D; Tan W; Lin D
    Mol Carcinog; 2009 Dec; 48(12):1131-8. PubMed ID: 19554573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.
    Li F; Ma X; Du L; Shi L; Cao Q; Li N; Pang T; Liu Y; Kijlstra A; Yang P
    Clin Exp Immunol; 2019 Aug; 197(2):230-236. PubMed ID: 30921471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: A case-control study.
    Yang J; Liu J; Chen Y; Tang W; Liu C; Sun Y; Chen J
    Medicine (Baltimore); 2019 Jul; 98(29):e16266. PubMed ID: 31335675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA4 polymorphisms and de novo malignancy risk after renal transplantation in Chinese recipients.
    Guo YF; Qiu JX; Guo F; Liu Y; Shang MH
    Biomed Res Int; 2015; 2015():986780. PubMed ID: 25667935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.
    Duan S; Zhang G; Han Q; Li Z; Liu Z; Chen J; Lv Y; Li N; Wang Y; Li M; Lou S; Yang M; Zhu Q; Xing F
    Mol Biol Rep; 2011 Nov; 38(8):5125-32. PubMed ID: 21161390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of any association of the CTLA-4 +49 G/A polymorphism with breast cancer risk in a North Indian population.
    Minhas S; Bhalla S; Shokeen Y; Jauhri M; Saxena R; Verma IC; Aggarwal S
    Asian Pac J Cancer Prev; 2014; 15(5):2035-8. PubMed ID: 24716930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
    Xiao W; Zhang Q; Deng XZ; Jiang LF; Zhu DY; Pei JP; Ge CY; Li BJ; Wang CJ; Zhang JH; Zhou ZX; Ding WL; Xu XD; Yue M
    Infect Genet Evol; 2015 Aug; 34():52-60. PubMed ID: 26079279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
    Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
    Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population.
    Liu J; Li J; Li T; Wang T; Li Y; Zeng Z; Li Z; Chen P; Hu Z; Zheng L; Ji J; Lin H; Feng G; Shi Y
    Brain Behav Immun; 2011 Mar; 25(3):429-33. PubMed ID: 21040781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.